The family *Caliciviridae* includes small non-enveloped viruses with single-stranded, positive-polarity RNA genomes of 7.4--8.3 kilobases \[[@r7]\]. The family consists of the *Vesivirus* (VESV), *Lagovirus*, *Nebovirus*, *Norovirus* (NoV) and *Sapovirus* (SaV) genera, as well as unassigned viruses \[[@r6], [@r12]\]. Although caliciviruses are known to infect a broad range of animals, including humans, swine, cattle, rabbits and mice, each calicivirus is generally thought to have high specificity for its host species. In swine, viruses detected to date have been classified into 3 established genera in the family *Caliciviridae*; SaV \[[@r1], [@r9], [@r11], [@r13], [@r14], [@r16],[@r17],[@r18],[@r19], [@r24], [@r28]\], NoV \[[@r15],[@r16],[@r17], [@r19], [@r21], [@r24], [@r28]\] and VESV \[[@r20]\]. Moreover, newly recognized caliciviruses, St-Valerien-like viruses (SVVs), were first identified in the feces of asymptomatic finisher swine in the province of Quebec, Canada, and were proposed as members of a potential genus of *Caliciviridae* \[[@r12]\]. SVV strains were also detected in swine in Italy and the U.S.A. \[[@r5], [@r22]\]. These Italian and North American SVV strains showed a close genetic relationship. However, the prevalence and genetic diversity of SVV in countries other than Canada, Italy and the U.S.A. are unknown. In this study, we report the genome structure and phylogenetic properties of SVV detected in asymptomatic fattening swine in Japan. In addition, we describe here our attempts to produce baculovirus-expressed virus-like particles (VLPs) using the capsid protein-coding region of the Japanese SVV genome.

We collected a total of 76 fecal samples from 71 healthy and 5 sick swine at farms in Kanagawa and Tochigi prefectures. Swine were aged as follows; 16 nursing swine (1 to 3 weeks), 10 postweaning swine (4 to 10 weeks), 28 fattening swine (11 to 19 weeks), 17 finisher swine (20 to 24 weeks) and 5 unknown. All fresh fecal samples were placed in sterilized tubes and stored at −80°C until use. Samples were prepared as 10% suspensions in sterilized phosphate-buffered saline. Prepared fecal suspensions were centrifuged at 20,000 × *g* for 5 min at 4°C, and supernatants were collected. Total RNAs were extracted from 140 *µl* of supernatants using the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, U.S.A.). Yeast RNA (Applied Biosystems, Foster City, CA, U.S.A.) was used as a carrier. For screening, the specific primer set for calicivirus genome, P290 (sense; 5′-GATTACTCCAAGTGGGACTCCAC −3′) and P289 (anti-sense; 5′-TGACAATGTAATCATCACCATA −3′), was used. The primers were broadly reactive, targeting highly conserved motifs of the RNA-dependent RNA polymerase coding region of the caliciviruses \[[@r10]\]. Reverse transcriptase polymerase chain reaction (RT-PCR) was performed using the PrimeScript^®^ One Step RT-PCR Kit Ver.2 (Dye Plus) (TAKARA, Otsu, Japan) in accordance with the manufacturer's instructions. The expected size of the amplicon (311 bp) was analyzed by 2% agarose gel electrophoresis with SYBR safe DNA gel stain (Invitrogen, Carlsbad, CA, U.S.A.) and was visualized by UV. Amplicons were purified using the QIAquick Gel Extraction Kit (QIAGEN). Nucleotide sequences of amplicons were determined using an automated sequencer ABI3130 (Applied Biosystems) and the Big Dye Terminator Cycle Sequencing Kit ver. 3.1 (Applied Biosystems) and were assembled by ATGC computer software (Genetyx Corporation, Tokyo, Japan). To find homologous sequences, we performed a BLASTn search (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&BLAST_PROGRAMS=megaBlast&PAGE_TYPE=BlastSearch) of the Gene bank nucleotide database. The complete genome sequence of SVV in the sample was also determined with sequence-specific primers ([Table 1](#tbl_001){ref-type="table"}Table 1.Primers used in this studyPrimerLocationSenceSequence (5′-3′)UsingP290^a)^3674--3696+GATTACTCCAAGTGGGACTCCACRT-PCR/3′RACE PCR/SequencingP289^a)^3981--3962-TGACAATGTAATCATCACCATART-PCR/Sequencing1st-Anchor25.TXR1-GCACATGACTACGGACTCAGGCGAT3′RACE PCRAnchor30+T3′ end-GCACATGACTACGGACTCAGGCGAT-3′RACE PCRACATCAGCATGGAGCT (27)St-V-1F3867--3888+TACTGAACTGTGTGGCACACTGSequencingSt-V-2F4480--4501+TCTTCCAGAGAACACGGCAGGCSequencingSt-V-3F5009--5031+TTTGCCTTCACCATGGTGGTGCCSequencingSt-V-4F5378--5397+GCAGAATACAACCCTGCCGASequencingSt-V-5F5869--5891+TTACTTCACCTTCCTGAGGTGGGSequencingSt-V-7F442--461+CGTTCCACACCAACCTTGGGSequencingSt-V-8F976--998+GATCTTGCATGACTCTTGTGCGGSequencingSt-V-9F1557--1578+ACATCTATGTCCGTTCCCAGGCSequencingSt-V-10F2107--2128+CCAAGACCTCTTGACCATCACCSequencingSt-V-11F2618--2638+CGTAACCCAACACCACTTCTGSequencingSt-V-12F3128--3148+CGTAACCCAACACCACTTCTGSequencingSt-V-13F3736--3755+GACCAAACTGTCCACCTTCCSequencingSt-V-14F166--186+CGGTGTGTACTTGTCACATGGSequencingSt-V-15F1--22+GTGATTTGCAATGTCTGTTACGSequencingSt-V-2R6009--5989-GCTGGCGACCTATTTTCTACCSequencingSt-V-3R5528--5509-GGTGCAGGTGATGGCCTCAASequencingSt-V-4R5116--5097-ATCCCAGGTTCCCAGTTGGCSequencingSt-V-5R4608--4587-GCCCAGATACCACAACCAACCASequencingSt-V-6R4129--4110-GGAGGACACGTTGGGAAGGASequencingSt-V-7R3556--3537-GGGTTTTCGGACCTGTGACASequencingSt-V-8R3060--3039-TTGCTGATGGCACACACCTCTGSequencingSt-V-9R2489--2470-GGAGGAACCAGGCTTTCAGGSequencingSt-V-10R1909--1888-ACAGCCCTTCAGACTCAACTCCSequencingSt-V-11R1255--1236-TGGCAACTGCGATAGCACGCSequencingSt-V-12R622--602-CTCTACCACTTACTTGCCACCSequencingSt-V-13R258--239-GTCGTTCGCACCATCTCACASequencingSt-V-A1R504--485-GAGCAGGACTACGACTGCAA5′RACE PCRSt-V-A2R482--461-GGAACTTCCCATTAGGATCC5′RACE PCRSt-V-S1F508--527+CAACACACACACGATGCTTG5′RACE PCRSt-V-S2F544--563+CCTGAGGTTTCTTTCCAAGG5′RACE PCRSt-V-PR^b)^569--582-(P) CTCAAAGTGCTCAC5′RACE PCRSt-V-EcoR I F^c)^+TATTG[GAATTC]{.ul}GAAGCCATGGAGCT-VLPGGAGGGTGTGASt-V-Sal I R^c)^-ATATC[GTCGAC]{.ul}T (30) AATGAGTTTTC-VLPAAAGCTCAGACCAATCTATAGTACa) Primers were published previously \[[@r9]\]. b) 5′ end-phosphorylated RT primer. c) Underline indicates a restriction site.). The 5′ and 3′ terminal sequences were amplified by 5′ and 3′ RACE methods using the 5′-Full RACE Core Set (TAKARA) and the PrimeScript^®^ II High Fidelity RT-PCR Kit (TAKARA), respectively. In the 5′ RACE method, 5′ end phosphorylated primer, ST-V-PR, was used for the RT reaction. After degradation of RNA and circularization and/or formation of concatemers of the cDNA by T4 RNA ligase, the 5′ terminal sequence (unknown region) in the cDNA became flanked with known sequence regions. The region including the 5′ terminal sequence was amplified by 1st and 2nd PCR with external (St-V-S1F/ St-V-A1R) and internal (St-V-S2F/ St-V-A2R) primer sets, respectively ([Table 1](#tbl_001){ref-type="table"}). In the 3′ RACE method, the adaptor sequence was anchored at the 3′ terminal sequence using the Anchor30+T primer in the RT reaction. The 3′ terminal sequence was amplified by PCR with P290/ 1st-Anchor25.TXR1 primer set. The SVV nucleotide sequences were determined by direct sequencing as described above. Phylogenetic analyses were performed using the Neighbor-Joining (NJ) method with MEGA ver. 5.05 (http://www.megasoftware.net/).

In this study, 2.6% (2/76) sample sequences (NUP-24/JP) detected from swine aged 4 months were identified as SVV positive. Because both swine were kept in the same pen and nucleotide sequences of the 2 samples showed complete accordance, we assumed that these sequences were derived from one strain (NUP-24/JP). The NUP-24/JP genome (Genbank accession No.: AB863586) had 6,409 nucleotides (exclude poly-A) and included two open reading frames (ORF1 and ORF2) with 5,940 and 453 nucleotides, respectively. Homologies of the ORF1 and ORF2 amino acid and nucleotide sequences (ORF1: 1,979 aa and 5,940 nt, ORF2: 150 aa and 453 nt) of the NUP-24/JP with other SVV strains \[[@r5], [@r12], [@r22]\] were as follows: full-sequence, 89.0--94.5%; ORF1aa, 97.5--99.0%; ORF1nt, 88.7--94.6%; ORF2aa, 92.0--97.3% and ORF2nt, 87.6--95.8%. Amino acid motifs and putative cleavage sites of SVV \[[@r12]\] were also conserved (data not shown). The NJ-tree based on the complete nucleotide sequences of the NUP-24/JP and other caliciviruses indicated that the NUP-24/JP was included in the SVV cluster, particularly close to the NC-WGP93C/US strain \[[@r22]\] ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Phylogenetic relationships of caliciviruses, including St-Valerien-like virus strains. The tree of complete genome sequences was constructed by the neighbor-joining method and was supported by 1,000 bootstrap replications. The NUP-24/JP strain identified in this study is indicated with a closed circle. The Genbank accession numbers of sequences are as follows: AB104/CAN, FJ355930; AB90/CAN, FJ355928; F15-10/CAN; FJ355929; NUP-24/JP, AB863586; NC-WGP93C/US, GU592498; Tulane, EU391643; MNV-1, DQ285629; Jena, AJ011099; Norwalk, M87661; Manchester, X86560; PEC, AF182760; FCV-USDA, AY560118; SMSV-1, U15301; BEC-NB, AY082891; BEC-Newbury, DQ013304; EBHSV-GD, Z69620; and RHDV-FRG, M67473.). Results of phylogenetic analyses revealed that SVVs including NUP-24/JP showed high nucleotide homologies, although these strains were detected in the regions remote from one another (Canada, Italy, U.S.A. and Japan). This suggests that SVV is prevalent in swine in regions other than Europe and North America.

Other swine caliciviruses are known to show genetic diversity. Swine SaVs mainly comprise one genogroup (GIII), as well as multiple genogroups that have been proposed, but not yet classified (GVI, GVII, GVIII, GIX?, GX? and GXI?) \[[@r19], [@r25], [@r26], [@r28]\]. Swine NoVs belong to one genogroup (GII), but are subdivided into three genotypes (GII/11, GII/18 and GII/19) \[[@r23], [@r26]\]. The amino acid sequence homologies of their capsid regions are 31.6--99.8% for SaVs \[[@r19]\] and 70.0--98.0% for NoVs \[[@r23]\]. A close relationship between SVVs (≥95.5%) showed in the phylogenetic tree ([Fig. 1](#fig_001){ref-type="fig"}) raised the possibility that they have high genetic identity. There may be only 1 genotype within SVVs \[[@r22]\], although these homologies were based on nucleotide sequence data from small numbers of SVV. Further epidemiological studies of SVVs will thus be necessary.

We attempted to propagate the NUP-24/JP strain using three cell lines; swine kidney (LLC-PK1), porcine intestinal epithelial (PIE) and Vero cells. Infection studies using LLC-PK1 cells were performed with bile acids, glycochenodeoxycholic acid and taurochenodeoxycholic acid, because it has been reported that bile acids in intestinal contents were essential for growth of swine SaVs in cultured cells \[[@r2], [@r3]\]. Unfortunately, we found neither a cytopathic effect of SVV nor an increase in viral RNA in any cell line tested (data not shown). This suggests that SVV may have different infectivity against cultured cells when compared with swine SaVs, although this could be attributed to low viral concentrations in the samples used in this study.

As propagation in cultured cells was unsuccessful, we next attempted to produce VLPs using the capsid protein-coding region of NUP-24/JP genome and the Bac-to-Bac^®^ Baculovirus Expression System (Invitrogen), in accordance with a previously reported method \[[@r4]\]. Briefly, the 3′-end region of the SVV genome (2,010 nt), including the VP1 and VP2 genes with 3′ UTR sequence, was amplified by RT-PCR with primers St-V-EcoRIF (5′-TATTG[GAATTC]{.ul}GAAGCCATGGAGCTGGAGGGTGTGA-3′; *Eco*RI site underlined) and St-V-SalIR (5′-ATATC[GTCGAC]{.ul}T^30^AATGAGTTTTCAAAGCTCAGACCAATCTATAGTAC-3′; *Sal*I site underlined). The amplified DNA was ligated into the site between *Eco*RI and *Sal*I of the pFastBacI^®^ vector plasmid with the Rapid DNA Ligation Kit (Roche Diagnostics GmbH, Mannheim, Germany). The ligation product was cloned into DH5α *E. coli* (TOYOBO, Osaka, Japan). Recombinant pFastBacI^®^ vector plasmids were harvested with the PureYield™ Plasmid Miniprep System Kit (Promega, Madison, WI, U.S.A.) and were transformed into the DH10Bac^™^*E. coli* (Invitrogen) for transposition of the VP1 gene into Bacmid DNA. Colonies containing recombinant Bacmid DNA were selected using X-Gal color screening, and the Bacmid DNA was harvested with the PowerPrep HP Bac Buffer Kit (Origene, Rockville, MD, U.S.A.). The recombinant capsid protein was produced in *Spodoptera frugiperda* (Sf9) insect cells by transfection of the recombinant Bacmid DNA with the Lipofectamine LTX PLUS^TM^ Reagents (Invitrogen). Supernatant was harvested at 5 days post-inoculation as P1 recombinant baculovirus stock. The P1 stock was amplified by inoculation into Sf9 cells to generate high-titer viral stock. Amplification was performed twice, and each supernatant was harvested at 5 days post-inoculation and was stored at −80°C as P2 and P3 stock, respectively. Baculovirus particles and cell debris were removed from the P3 stock by centrifugation at 1,200 × *g* for 5 min at 4°C and 20,000 × *g* for 30 min at 4°C and by filtration with φ 0.1-*µ*m filter. The P3 stock was further centrifuged at 150,000 × *g* for 3 hr at 4°C in a Beckman SW28.1 rotor to concentrate VLPs expected to be composed of the recombinant capsid protein. After centrifugation, the pellet containing VLPs was resuspended in Grace's Medium (GIBCO^®^, Carlsbad, CA, U.S.A.), and 5 m*l* of CsCl solution (1.27 g/cm^3^) containing the resuspended VLPs was prepared with Grace's Medium. The CsCl solution with the VLPs was centrifuged at 243,000 × *g* for 18 hr at 20°C in a Beckman SW50.1 rotor to obtain fraction including VLPs by density gradient centrifugation. VLPs in the fraction, discernible as a white band, were collected, diluted more than 10-fold with Grace's Medium and recovered by centrifugation at 150,000 × *g* for 3 hr at 4°C. After removing the supernatant, purified VLPs were resuspended in Grace's Medium. Expression of capsid protein in the suspension was confirmed by SDS-PAGE and Coomassie brilliant blue (CBB) staining. VLPs were examined by electron microscopic observation.

SDS-PAGE and CBB staining showed a single band of approximately 55 kDa ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Production of SVV VLPs using the Bac-to-Bac^®^ Baculovirus Expression System. (A) SDS-PAGE of the recombinant capsid protein of the SVV, NUP-24/JP strain. Lane 1, capsid protein of NUP-24/JP VLPs concentrated from supernatants of Sf9 insect cells. ; Lane 2, Precision Plus Protein^TM^ Standards (BIO-RAD). Arrow indicates SVV VP1 protein band. (B) EM analysis of the two types of VLP of SVV NUP-24/JP strain. The larger type has a diameter of approximately 45 nm with a characteristic cup structure on the surface. The smaller type has a diameter of approximately 30 nm. Bar, 100 nm.), which corresponds to the molecular mass of VP1 of SVV \[[@r12]\]. Electron microscopic observation detected VLPs of two sizes ([Fig. 2B](#fig_002){ref-type="fig"}). The larger type had a diameter of approximately 45 nm with a characteristic cup structure on the surface, and the smaller type had a diameter of approximately 30 nm. The assembly of VLPs of two sizes (diameters of 38 and 23 nm, respectively) has previously been reported in Norwalk virus (a prototype strain of human NoV) \[[@r27]\]. The authors suggested that VLPs of both sizes were composed of a 58 kDa capsid protein and that the difference in VLP size depended on the number of units of capsid protein forming the VLPs. VLPs of 2 sizes (diameters 41--48 and 26--31 nm) have been also observed in SaV (NK24 strain) \[[@r8]\]. In our study on SVV, as only the 55 kDa band was detected on SDS-PAGE, VLPs of 2 sizes also appear to be constructed from the intact capsid protein, VP1 of SVV. In addition, White *et al*. \[[@r27]\] indicated that the both VLPs have similar antigenic properties when analyzed with polyclonal and monoclonal antibodies. The VLPs of SVV, NUP24/JP successfully produced in this study should be useful as antigens for studying the seroprevalence rate of SVV infection in swine, such as age, species or farm-dependent differences in the prevalence of SVV-specific antibody.

In conclusion, we detected the SVV genome sequence of the NUP-24/JP strain in asymptomatic swine in Japan, thus suggesting that SVV is prevalent worldwide. Although we were unable to propagate NUP-24/JP using cell lines, we successfully produced VLPs, which would be useful for seroprevalence studies in the future.
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